QSOX1 inhibits autophagic flux in breast cancer cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Poillet, Laura ^a   Pernodet, Nicolas ^a   Boyer Guittaut, Michaël ^a   Adami, Pascale ^a   Borg, Christophe ^a   Jouvenot, Michèle ^a   Delage Mourroux, Régis ^a   Despouy, Gilles ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P62; PROTEIN QSOX1; UNCLASSIFIED DRUG; AMINO ACID; OXIDOREDUCTASE; QSOX1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BREAST CANCER; CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CELL FUSION; CELL INVASION; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYSOSOME; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; DEFICIENCY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MEMBRANE FUSION; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; PHAGOSOME; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR CELL LINE; TUMOR VOLUME;

AMINO ACIDS; ANIMALS; AUTOPHAGY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INJECTIONS, SUBCUTANEOUS; LYSOSOMES; MEMBRANE FUSION; MICE; NEOPLASM TRANSPLANTATION; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; PHAGOSOMES; SIGNAL TRANSDUCTION; TUMOR BURDEN;

EID: 84899829219     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086641     Document Type: Article

References (57)

1. Musard JF, Sallot M, Dulieu P, Fraichard A, Ordener C, et al. (2001) Identification and expression of a new sulfhydryl oxidase SOx-3 during the cell cycle and the estrus cycle in uterine cells. Biochem Biophys Res Commun 287: 83-91. (Pubitemid 32912466)
2. Thorpe C, Hoober KL, Raje S, Glynn NM, Burnside J, et al. (2002) Sulfhydryl oxidases: emerging catalysts of protein disulfide bond formation in eukaryotes. Arch Biochem Biophys 405: 1-12. (Pubitemid 35026160)
3. Heckler EJ, Rancy PC, Kodali VK, Thorpe C (2008) Generating disulfides with the Quiescin-sulfhydryl oxidases. Biochim Biophys Acta 1783: 567-577. (Pubitemid 351458553)
4. Tury A, Mairet-Coello G, Poncet F, Jacquemard C, Risold PY, et al. (2004) QSOX sulfhydryl oxidase in rat adenohypophysis: localization and regulation by estrogens. J Endocrinol 183: 353-363. (Pubitemid 39562716)
5. Benayoun B, Esnard-Feve A, Castella S, Courty Y, Esnard F (2001) Rat seminal vesicle FAD-dependent sulfhydryl oxidase. Biochemical characterization and molecular cloning of a member of the new sulfhydryl oxidase/quiescin Q6 gene family. J Biol Chem 276: 13830-13837.
6. Hoober KL, Joneja B, White HB, 3rd, Thorpe C (1996) A sulfhydryl oxidase from chicken egg white. J Biol Chem 271: 30510-30516. (Pubitemid 26404059)
7. Ilani T, Alon A, Grossman I, Horowitz B, Kartvelishvily E, et al. (2013) A secreted disulfide catalyst controls extracellular matrix composition and function. Science 341: 74-76.
8. Song H, Zhang B, Watson MA, Humphrey PA, Lim H, et al. (2009) Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Oncogene 28: 3307-3319.
9. Antwi K, Hostetter G, Demeure MJ, Katchman BA, Decker GA, et al. (2009) Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors. J Proteome Res 8: 4722-4731.
10. Hellebrekers DM, Castermans K, Vire E, Dings RP, Hoebers NT, et al. (2006) Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications. Cancer Res 66: 10770-10777. (Pubitemid 44876972)
11. Pernodet N, Hermetet F, Adami P, Vejux A, Descotes F, et al. (2012) High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients. Breast Cancer Res 14: R136.
12. Hellebrekers DM, Melotte V, Vire E, Langenkamp E, Molema G, et al. (2007) Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Res 67: 4138-4148. (Pubitemid 46815059)
13. Coppock DL, Kopman C, Scandalis S, Gilleran S (1993) Preferential gene expression in quiescent human lung fibroblasts. Cell Growth Differ 4: 483-493.
14. Coppock D, Kopman C, Gudas J, Cina-Poppe DA (2000) Regulation of the quiescence-induced genes: quiescin Q6, decorin, and ribosomal protein S29. Biochem Biophys Res Commun 269: 604-610. (Pubitemid 30440348)
15. Morel C, Adami P, Musard JF, Duval D, Radom J, et al. (2007) Involvement of sulfhydryl oxidase QSOX1 in the protection of cells against oxidative stressinduced apoptosis. Exp Cell Res 313: 3971-3982. (Pubitemid 350010932)
16. Katchman BA, Antwi K, Hostetter G, Demeure MJ, Watanabe A, et al. (2011) Quiescin sulfhydryl oxidase 1 promotes invasion of pancreatic tumor cells mediated by matrix metalloproteinases. Mol Cancer Res 9: 1621-1631.
17. Katchman BA, Ocal IT, Cunliffe HE, Chang YH, Hostetter G, et al. (2013) Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer. Breast Cancer Res 15: R28.
18. Soloviev M, Esteves MP, Amiri F, Crompton MR, Rider CC (2013) Elevated transcription of the gene QSOX1 encoding quiescin Q6 sulfhydryl oxidase 1 in breast cancer. PLoS One 8: e57327.
19. Galluzzi L, Vicencio JM, Kepp O, Tasdemir E, Maiuri MC, et al. (2008) To die or not to die: that is the autophagic question. Curr Mol Med 8: 78-91. (Pubitemid 351516828)
20. Cuervo AM (2004) Autophagy: in sickness and in health. Trends Cell Biol 14: 70-77.
21. Xie Z, Klionsky DJ (2007) Autophagosome formation: core machinery and adaptations. Nat Cell Biol 9: 1102-1109. (Pubitemid 47500484)
22. Zhou S, Zhao L, Kuang M, Zhang B, Liang Z, et al. (2012) Autophagy in tumorigenesis and cancer therapy: Dr. Jekyll or Mr. Hyde? Cancer Lett 323: 115-127.
23. Liu EY, Ryan KM (2012) Autophagy and cancer-issues we need to digest. J Cell Sci 125: 2349-2358.
24. Lozy F, Karantza V (2012) Autophagy and cancer cell metabolism. Semin Cell Dev Biol 23: 395-401.
25. Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, et al. (2007) Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21: 1367-1381. (Pubitemid 46871040)
26. Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, et al. (2007) Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 21: 1621-1635. (Pubitemid 47026367)
27. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, et al. (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676. (Pubitemid 129516338)
28. Liang C, Feng P, Ku B, Dotan I, Canaani D, et al. (2006) Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 8: 688-699.
29. Kang MR, Kim MS, Oh JE, Kim YR, Song SY, et al. (2009) Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol 217: 702-706.
30. Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, et al. (1999) Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59: 59-65. (Pubitemid 29339873)
31. Harris AL (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47.
32. Brahimi-Horn MC, Bellot G, Pouyssegur J (2011) Hypoxia and energetic tumour metabolism. Curr Opin Genet Dev 21: 67-72.
33. Wei H, Wei S, Gan B, Peng X, Zou W, et al. (2011) Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev 25: 1510-1527.
34. Haan C, Behrmann I (2007) A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background. J Immunol Methods 318: 11-19. (Pubitemid 46026809)
35. Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, et al. (2010) p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 285: 22576-22591.
36. Duran A, Linares JF, Galvez AS, Wikenheiser K, Flores JM, et al. (2008) The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 13: 343-354. (Pubitemid 351446193)
37. Puissant A, Auberger P (2010) AMPK- and p62/SQSTM1-dependent autophagy mediate resveratrol-induced cell death in chronic myelogenous leukemia. Autophagy 6: 655-657.
38. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, et al. (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8: 445-544.
39. Arduino DM, Esteves AR, Cortes L, Silva DF, Patel B, et al. (2012) Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic. Hum Mol Genet 21: 4680-4702.
40. Macintosh RL, Timpson P, Thorburn J, Anderson KI, Thorburn A, et al. (2012) Inhibition of autophagy impairs tumor cell invasion in an organotypic model. Cell Cycle 11: 2022-2029.
41. Dalby KN, Tekedereli I, Lopez-Berestein G, Ozpolat B (2010) Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 6: 322-329.
42. Clarke R, Cook KL, Hu R, Facey CO, Tavassoly I, et al. (2012) Endoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fate. Cancer Res 72: 1321-1331.
43. Levine B, Yuan J (2005) Autophagy in cell death: an innocent convict? J Clin Invest 115: 2679-2688. (Pubitemid 41434392)
44. Kroemer G, Levine B (2008) Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 9: 1004-1010.
45. Lipinski MM, Hoffman G, Ng A, Zhou W, Py BF, et al. (2010) A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. Dev Cell 18: 1041-1052.
46. Lim J, Hao T, Shaw C, Patel AJ, Szabo G, et al. (2006) A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125: 801-814. (Pubitemid 43732348)
47. N'Diaye EN, Debnath J, Brown EJ (2009) Ubiquilins accelerate autophagosome maturation and promote cell survival during nutrient starvation. Autophagy 5: 573-575.
48. Yun Lee D, Arnott D, Brown EJ (2013) Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery. EMBO Rep 14: 373-381.
49. Lipinski MM, Zheng B, Lu T, Yan Z, Py BF, et al. (2010) Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci U S A 107: 14164-14169.
50. Berardi DE, Campodonico PB, Diaz Bessone MI, Urtreger AJ, Todaro LB (2011) Autophagy: friend or foe in breast cancer development, progression, and treatment. Int J Breast Cancer 2011: 595092.
51. Debnath J (2011) The multifaceted roles of autophagy in tumors-implications for breast cancer. J Mammary Gland Biol Neoplasia 16: 173-187.
52. Karantza-Wadsworth V, White E (2007) Role of autophagy in breast cancer. Autophagy 3: 610-613.
53. Gong C, Bauvy C, Tonelli G, Yue W, Delomenie C, et al. (2013) Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene 32: 2261-2272.
54. Yang S, Wang X, Contino G, Liesa M, Sahin E, et al. (2011) Pancreatic cancers require autophagy for tumor growth. Genes Dev 25: 717-729.
55. Amaravadi RK (2012) Autophagy and tumor cell invasion. Cell Cycle 11: 3718-3719.
56. Puissant A, Fenouille N, Auberger P (2012) When autophagy meets cancer through p62/SQSTM1. Am J Cancer Res 2: 397-413.
57. Mathew R, Karantza-Wadsworth V, White E (2009) Assessing metabolic stress and autophagy status in epithelial tumors. Methods Enzymol 453: 53-81.